iShares Core S&P Small-Cap ETF (IJR)
108.65
0.00 (0.00%)
Previous Close | 108.65 |
---|---|
Open | - |
Day's Range | N/A - N/A |
52 Week Range | 101.85 - 128.61 |
Volume | 0 |
Market Cap | 818.35M |
Dividend & Yield | 2.060 (1.90%) |
1 Month Average Volume | 4,107,883 |
News & Press Releases

The company cited an "uncertain" macro environment, a shift in consumer confidence, and headwinds from unseasonal weather in the U.S.
Via Stocktwits · March 6, 2025

CEO Adam Grossman highlighted a 65% year-over-year jump in total revenue and a staggering 309% increase in adjusted EBITDA for 2024.
Via Stocktwits · March 3, 2025

Annual revenue from its MS drug, Briumvi, more than tripled, with U.S. net product revenue reaching $103.6 million in the fourth quarter and $310 million for the full year.
Via Stocktwits · March 3, 2025

Citi upgraded Bath & Body Works from ‘Neutral’ to ‘Buy’ following the company’s post-earnings share sell-off
Via Stocktwits · March 3, 2025

cars-com-stock-snags-another-price-target-cut
Via Stocktwits · March 2, 2025

The revenue miss was due to a slowdown in spending from existing customers that began in October and one of the company’s largest customers pulling back its business significantly.
Via Stocktwits · February 28, 2025

Sentiment on Stocktwits remained ‘neutral’ compared to a week ago
Via Stocktwits · February 28, 2025

Its first quarter 2025 earnings per diluted share is expected to be between $0.36 and $0.43, compared to the consensus estimate of $0.44.
Via Stocktwits · February 28, 2025

Sentiment on Stocktwits turned ‘bearish’ compared to ‘bullish’ a week ago
Via Stocktwits · February 27, 2025

Segment-wise, revenue at ‘Topgolf’remained flat at $439.0 million
Via Stocktwits · February 25, 2025

On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide.
Via Stocktwits · February 24, 2025

CEO Andrew Dudum acknowledged retail shareholders in a post on X, highlighting their deep research on the company and announcing plans to engage them directly on future earnings calls.
Via Stocktwits · February 24, 2025

Shake Shack’s Q4 saw “broad-based strength across the business”
Via Stocktwits · February 21, 2025

Brand Tripadvisor accounted for roughly half of the total revenue but witnessed a 6% revenue drop.
Via Stocktwits · February 20, 2025

Leslie’s recently reported mixed first-quarter results.
Via Stocktwits · February 20, 2025

Etsy expects its consolidated first quarter 2025 GMS will decline at a rate similar to the year-over-year performance reported for the fourth quarter
Via Stocktwits · February 20, 2025

One analyst warned that elevated growth expectations could lead to near-term volatility as the company introduces its FY25 guidance.
Via Stocktwits · February 19, 2025

A poll of over 4,000 respondents found that 47% believe the stock will continue its climb past $60, while 44% expect a significant pullback for profit-taking.
Via Stocktwits · February 18, 2025

The company expects Services to continue to drive its business performance in 2025 and RR&O to remain pressured.
Via Stocktwits · February 14, 2025

Sentiment on Stocktwits improved to ‘bullish’ from ‘bearish' last week.
Via Stocktwits · February 12, 2025

The commercial aired Sunday night on Fox and positioned obesity as "America's deadliest epidemic" while criticizing the $160 billion weight-loss industry and the broader healthcare system.
Via Stocktwits · February 10, 2025

Sentiment on Stocktwits rose further into the ‘extremely bullish’ territory.
Via Stocktwits · February 7, 2025

The company’s quarterly revenue fell 26.6% to $1.16 billion compared to last year. Analysts, on average, expected the company to post $1.25 billion in revenue.
Via Stocktwits · February 6, 2025

Cal-Maine plans to fund the acquisition with available cash on hand.
Via Stocktwits · February 3, 2025

Sentiment on Stocktwits jumped to ‘extremely bullish’ from ‘bullish’ a day ago.
Via Stocktwits · January 31, 2025